Lyra Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.20

+0.00 (+0.00%)

As of Sep 22, 6:01 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +6,900.0% upside

Low Target $9.32

Average Target $14.00

High Target $16.42

Current Price $0.20

Current
$0.20

Target
$14.00

$9.32 $14.00 avg $16.42

Scenario Analysis

Bear Case

$9.32

4,560.0%

Low target

Base Case

$14.00

+6,900.0%

Avg target

Bull Case

$16.42

+8,110.0%

High target

Risk/Reward

1.8x

Balanced

Price in Context

Target vs 52W High

$14.00

+60.0% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%